US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies(Delisted)

Watchlist
  • 131.870
  • 0.0000.00%
Close Apr 1 16:00 ET
14.05BMarket Cap-183.15P/E (TTM)

Intra-Cellular Therapies(Delisted) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
47.24%680.5M
51.49%199.22M
39.23%175.16M
46.44%161.28M
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
Operating revenue
47.24%680.5M
51.49%199.22M
39.23%175.16M
46.44%161.28M
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
Cost of revenue
68.80%56.96M
90.67%20.41M
67.64%15.3M
58.51%11.35M
46.64%9.9M
65.07%33.75M
57.66%10.7M
56.05%9.13M
54.04%7.16M
113.98%6.75M
Gross profit
45.54%623.54M
48.02%178.82M
37.00%159.86M
45.60%149.92M
53.38%134.94M
87.34%428.43M
49.80%120.8M
76.74%116.68M
104.20%102.97M
178.42%87.98M
Operating expense
25.93%740.26M
34.29%208.02M
35.73%198.7M
18.32%177.65M
14.32%155.9M
19.40%587.81M
20.96%154.9M
20.34%146.39M
8.53%150.14M
30.80%136.37M
Selling and administrative expenses
23.09%504.49M
31.52%137.73M
25.56%132.1M
20.35%121.57M
14.32%113.09M
14.24%409.86M
10.66%104.72M
19.05%105.21M
0.70%101.01M
31.09%98.92M
Research and development costs
31.07%236.12M
38.43%70.29M
60.82%66.82M
12.83%56.18M
12.65%42.83M
33.72%180.14M
49.94%50.77M
24.87%41.55M
29.21%49.79M
30.92%38.02M
Other operating expenses
84.01%-351K
--0
40.50%-216K
83.13%-112K
96.00%-23K
-85.70%-2.2M
-36.01%-593K
---363K
-31.49%-664K
-138.59%-575K
Operating profit
26.77%-116.72M
14.37%-29.2M
-30.75%-38.85M
41.24%-27.72M
56.70%-20.95M
39.54%-159.38M
28.08%-34.1M
46.59%-29.71M
46.34%-47.18M
33.40%-48.39M
Net non-operating interest income expense
109.01%42.52M
101.06%12M
134.61%12.9M
155.19%11.56M
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
Non-operating interest income
109.01%42.52M
101.06%12M
134.61%12.9M
155.19%11.56M
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
Other net income (expense)
Income before tax
46.63%-74.2M
38.85%-17.2M
-7.16%-25.95M
62.10%-16.16M
66.20%-14.89M
45.74%-139.04M
36.10%-28.13M
54.74%-24.22M
50.75%-42.65M
38.93%-44.04M
Income tax
-25.63%473K
-170.76%-317K
769.77%374K
-57.78%57K
3,490.00%359K
10,500.00%636K
448K
4,200.00%43K
135K
100.00%10K
Net income
46.54%-74.68M
40.92%-16.89M
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
Net income continuous Operations
46.54%-74.68M
40.92%-16.89M
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
Minority interest income
Net income attributable to the parent company
46.54%-74.68M
40.92%-16.89M
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
46.54%-74.68M
40.92%-16.89M
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
Basic earnings per share
50.68%-0.72
46.67%-0.16
0.00%-0.25
64.44%-0.16
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
Diluted earnings per share
50.68%-0.72
46.67%-0.16
0.00%-0.25
64.44%-0.16
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 47.24%680.5M51.49%199.22M39.23%175.16M46.44%161.28M52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M
Operating revenue 47.24%680.5M51.49%199.22M39.23%175.16M46.44%161.28M52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M
Cost of revenue 68.80%56.96M90.67%20.41M67.64%15.3M58.51%11.35M46.64%9.9M65.07%33.75M57.66%10.7M56.05%9.13M54.04%7.16M113.98%6.75M
Gross profit 45.54%623.54M48.02%178.82M37.00%159.86M45.60%149.92M53.38%134.94M87.34%428.43M49.80%120.8M76.74%116.68M104.20%102.97M178.42%87.98M
Operating expense 25.93%740.26M34.29%208.02M35.73%198.7M18.32%177.65M14.32%155.9M19.40%587.81M20.96%154.9M20.34%146.39M8.53%150.14M30.80%136.37M
Selling and administrative expenses 23.09%504.49M31.52%137.73M25.56%132.1M20.35%121.57M14.32%113.09M14.24%409.86M10.66%104.72M19.05%105.21M0.70%101.01M31.09%98.92M
Research and development costs 31.07%236.12M38.43%70.29M60.82%66.82M12.83%56.18M12.65%42.83M33.72%180.14M49.94%50.77M24.87%41.55M29.21%49.79M30.92%38.02M
Other operating expenses 84.01%-351K--040.50%-216K83.13%-112K96.00%-23K-85.70%-2.2M-36.01%-593K---363K-31.49%-664K-138.59%-575K
Operating profit 26.77%-116.72M14.37%-29.2M-30.75%-38.85M41.24%-27.72M56.70%-20.95M39.54%-159.38M28.08%-34.1M46.59%-29.71M46.34%-47.18M33.40%-48.39M
Net non-operating interest income expense 109.01%42.52M101.06%12M134.61%12.9M155.19%11.56M39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M
Non-operating interest income 109.01%42.52M101.06%12M134.61%12.9M155.19%11.56M39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M
Other net income (expense)
Income before tax 46.63%-74.2M38.85%-17.2M-7.16%-25.95M62.10%-16.16M66.20%-14.89M45.74%-139.04M36.10%-28.13M54.74%-24.22M50.75%-42.65M38.93%-44.04M
Income tax -25.63%473K-170.76%-317K769.77%374K-57.78%57K3,490.00%359K10,500.00%636K448K4,200.00%43K135K100.00%10K
Net income 46.54%-74.68M40.92%-16.89M-8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M
Net income continuous Operations 46.54%-74.68M40.92%-16.89M-8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M
Minority interest income
Net income attributable to the parent company 46.54%-74.68M40.92%-16.89M-8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 46.54%-74.68M40.92%-16.89M-8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M
Basic earnings per share 50.68%-0.7246.67%-0.160.00%-0.2564.44%-0.1665.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.46
Diluted earnings per share 50.68%-0.7246.67%-0.160.00%-0.2564.44%-0.1665.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CAC Nantong Chemical
301665
+289.97%
KAIDE QUARTZ
835179
+29.97%
BING YANG TECHNOLOGY
836675
+22.35%
4
Hualan Group
301027
+20.02%
5
Hangzhou SDIC Microelectronics Inc.
688130
+20.01%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.